Navigation Links
Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial
Date:4/23/2008

pletion of clinical studies, the ability of ProMetic to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. You will find a more detailed assessment of the risks that could cause actual events or results to materially differ from our current expectations on page 21 of ProMetic's Annual Information Form for the year ended December 31, 2006, under the heading "Risk Factors". As a result, we cannot guarantee that any forward-looking statement will materialize. We assume no obligation to update any forward-looking statement even if new information becomes available, as a result of future events or for any other reason, unless required by applicable securities laws and regulations.


'/>"/>
SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
2. ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study
3. Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiologys Toughest Questions
4. 960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotechs Novel 5-FU Central Venous Catheter
5. USGI Medical Demonstrates First System for Gastrotomy Closure in NOTES
6. Job-related stress: NIST demonstrates fatigue effects in silicon
7. Brostallicin Trial Data Demonstrates Encouraging Anti-tumor Activity in Patients With Chemotherapy-Resistant Cancers
8. Magnifi Group Demonstrates Industrys First Interactive Educational Program (IEP) for Spine Fellows
9. ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients
10. Organons Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder
11. Recent Study Confirms Alimentary Healths Bifantis(R) Demonstrates Efficacy in the Treatment of Irritable Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
...re Wisconsin companies are expected to pitch their...re Forum . , ,Eight companies from Wisconsin are n...which this year will be in Minneapolis. , ,The fo... life sciences associations and the Biotechnology ...and medical device product and platform companies....
..., Wis. -- GenTel BioSurfaces, Inc., of Madison ...zymatic labeling technology for biomolecules and l...nTel will market and sell the Universal Linkage Sy...BV of Amsterdam, under its brand name Pandeia in ...e on GenTel,s PATH protein microarray technology p...
..., Wis. -- A report is due this fall that will he...ine whether and how to proceed with an IT project ...on was spent working to implement it over a five-y...ht with problems, including a lack of good project...fits Systems project (ABPS) for the UW System was ...
..., Wis. - Alfalight, Inc., a manufacturer of diode...tions markets worldwide, has received $7 million i...sday. , ,The financing package was led by GF Priva...t,s major previous investors. Those include ARCH ...F Ventures, CenterPoint Ventures, Venture Investor...
Other Biology Technology:Three more Wisconsin firms to present at venture forum 2UW working to salvage multi-million HR software project 2UW working to salvage multi-million HR software project 3UW working to salvage multi-million HR software project 4UW working to salvage multi-million HR software project 5Alfalight receives $7 million in expansion funding 2
(Date:7/25/2008)...en born with hydrocephalus, or "water on the brain...ay from the brain to reduce harmful pressure. , ... infection in children is very high for a variety ...gh another surgery to replace the shunt, bringing ...eurological complications and an increased risk of...
(Date:7/25/2008)...d ,green, can potentially contain a naturally occu...risk to public health according to a review paper ...rnal of the Science of Food and Agriculture (JSFA... the ,green, affected area is enough to eliminate ... also suggests that the levels of GA in potatoes c...
(Date:7/24/2008)...k up plants just as they do human athletes, but th...s to boost growth and development in plant cells i...lls. A new study by plant biologists at the Carneg... called proteomics to identify key links in the st...nt hormones activate genes could lead not only to ...
(Date:7/24/2008)...rus called cytomegalovirus (CMV), which most commo..., can also affect hospital intensive-care patients... Washington researchers have found. CMV infection ...ive-care unit (ICU) stays independent of other cau... JAMA , the Journal of the American Medical Assoc...
Breaking Biology News(10 mins):Antimicrobial sutures reduce infections in brain shunt surgery, study finds 2Plant steroids offer new paradigm for how hormones work 2Plant steroids offer new paradigm for how hormones work 3CMV infections affect more than just patients with compromised immune systems, researchers find 2TAX ALERT 3A Deductions for Long Term Care Insurance Premiums 14532 1TAX ALERT 3A Deductions for Long Term Care Insurance Premiums 14532 2Ingenuity Systems Extends Enterprise Level Software Agreement With GlaxoSmithKline 4029 1Ingenuity Systems Extends Enterprise Level Software Agreement With GlaxoSmithKline 4029 2Cell Therapeutics Inc 28CTI 29 Invest Northwest Presentation to be Webcast 4026 1Reducing HD risk naturally post menopause 14530 1Reducing HD risk naturally post menopause 14530 2
...hronic smoking affects nerve cells and alters the ...h presented today at the annual meeting of the Rad...s is the first imaging study to focus on the relat...endence," said Okan Gür, M.D., from the Department.... , Dr. Gür and colleagues used proton magneti...
...esearchers at the University of Southern Californi...om an enzyme family that, through its ability to m.... , Reporting in the Dec. 24 online edition of Na...e "unusual" crystal structure of the Apo2 enzyme. ... first mechanistic analysis of any of the APOBEC e...
...nvestigators at St. Jude Children,s Research Hospi... from certain pneumonia-causing bacteria can cause...ow antibiotic therapy can contribute to this damag...d by dying bacteria. The team also demonstrated in... , The study shows that pieces of cell walls from ...
... biologist at Washington University in St. Louis a... mammalian brain cells that keeps cells in synchro...rmone secretion and loco motor behaviors are coord... Ph.D., Washington University associate professor ...., a graduate student in Herzog’s lab who is now a...
Other Biology News:Smoking changes brain chemistry 2USC team reveals structure of APOBEC family protein 2Cell wall of pneumonia bacteria can cause brain and heart damage 2Cell wall of pneumonia bacteria can cause brain and heart damage 3Protein shown to rally biological clock 2
...The MasterPure™ Plant Leaf DNA Purification K... fresh plant leaf tissue. The protocol can be comp...o obtain larger amounts of DNA. The purified DNA c...stion, and Southern blotting. The MasterPure Kit w...
Caspase Activity Detector, SR-VAD-FMK Kit , 100 tests Consult technical datasheet for details.
HistoScan AP Universal Goat Kit
Agarose, high gelling temperature, Molecular Biology Grade from Research Organics, Inc.
Biology Products: